Form Health patients treated with semaglutide achieved weight loss exceeding “real world,” and even clinical trial, results.
Form Health patients who received intensive lifestyle therapy delivered virtually and semaglutide achieved an average weight loss of 13.6% at 12 months and 17.7% at 18 months, demonstrating the impact of comprehensive obesity care including behavioral support and lifestyle intervention. Form Health offers a comprehensive virtual care model that helps patients achieve significant weight loss and improved health. Key parts of unique care model include:
Download the report to learn how Form Health is transforming obesity and cardiometabolic care through our innovative virtual care solution.
No matter your size, industry, or population, we can help your organization form a healthier future.